Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Unboosted Atazanavir as Initial ART Therapy in China

This study has been completed.
BMS company
Information provided by (Responsible Party):
NCAIDS, National Center for AIDS/STD Control and Prevention, China CDC Identifier:
First received: October 24, 2011
Last updated: NA
Last verified: October 2011
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)